Then, CD133 was identified as a CSC marker in hepatocellular carcinoma (HCC),12 glioblastoma,13 colon tumors7 and ovarian cancers (OCs).14 However, CD133 alone cannot always indicate the CSC phenotype. The gene discussed is PROM1; the disease is hepatocellular carcinoma.